TSH-activated signaling pathways in thyroid tumorigenesis

Marcos Rivas1, Pilar Santisteban

  • 1Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, Arturo Duperier # 4, E-28029 Madrid, Spain.

Insights

Thyrotropin (TSH) signaling pathways regulate thyrocyte proliferation and are crucial for understanding thyroid pathology. This review details cAMP, Ras, and PLC/PKC pathways in thyroid tumor development.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Thyrotropin (TSH) is the primary regulator of thyrocyte differentiation and proliferation.
  • Understanding TSH-mediated signaling is critical for elucidating thyroid pathology mechanisms.
  • Thyroid diseases often involve dysregulated thyrocyte growth and transformation.

Purpose of the Study:

  • To review the signaling pathways activated by TSH in thyrocytes.
  • To explore the role of these pathways in TSH-induced proliferation.
  • To examine the involvement of TSH signaling in thyroid tumorigenesis.

Main Methods:

  • Literature review focusing on TSH signaling pathways.
  • Analysis of cAMP-dependent protein kinase (PKA) pathways.
  • Investigation of alternative pathways including small GTPases (Rap1, Ras) and their effectors (PI3K, RalGDS, Raf).
  • Discussion of the phospholipase C (PLC)/protein kinase C (PKC) cascade.

Main Results:

  • TSH-mediated proliferation is largely driven by cyclic adenosine monophosphate (cAMP).
  • cAMP activates both protein kinase A (PKA)-dependent and independent processes influencing cell cycle progression.
  • Ras GTPase and its effectors (PI3K, RalGDS, Raf) play significant roles in TSH-induced proliferation and oncogenesis.
  • The PLC/PKC cascade is also activated by TSH, contributing to thyrocyte proliferation and tumor development.

Conclusions:

  • TSH utilizes multiple signaling pathways, including cAMP/PKA, Ras, and PLC/PKC, to regulate thyrocyte proliferation.
  • These pathways are implicated in the initiation and progression of thyroid tumors.
  • Further characterization of TSH signaling is essential for understanding and potentially treating thyroid pathologies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...